Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 58

1.

Epitranscriptomic Addition of m5C to HIV-1 Transcripts Regulates Viral Gene Expression.

Courtney DG, Tsai K, Bogerd HP, Kennedy EM, Law BA, Emery A, Swanstrom R, Holley CL, Cullen BR.

Cell Host Microbe. 2019 Aug 14;26(2):217-227.e6. doi: 10.1016/j.chom.2019.07.005.

PMID:
31415754
2.

Extensive Epitranscriptomic Methylation of A and C Residues on Murine Leukemia Virus Transcripts Enhances Viral Gene Expression.

Courtney DG, Chalem A, Bogerd HP, Law BA, Kennedy EM, Holley CL, Cullen BR.

MBio. 2019 Jun 11;10(3). pii: e01209-19. doi: 10.1128/mBio.01209-19.

3.

Insights into the mechanisms underlying the inactivation of HIV-1 proviruses by CRISPR/Cas.

Mefferd AL, Bogerd HP, Irwan ID, Cullen BR.

Virology. 2018 Jul;520:116-126. doi: 10.1016/j.virol.2018.05.016. Epub 2018 May 29.

4.

Posttranscriptional m6A Editing of HIV-1 mRNAs Enhances Viral Gene Expression.

Kennedy EM, Bogerd HP, Kornepati AVR, Kang D, Ghoshal D, Marshall JB, Poling BC, Tsai K, Gokhale NS, Horner SM, Cullen BR.

Cell Host Microbe. 2017 Dec 13;22(6):830. doi: 10.1016/j.chom.2017.11.010. No abstract available.

5.

Epitranscriptomic Enhancement of Influenza A Virus Gene Expression and Replication.

Courtney DG, Kennedy EM, Dumm RE, Bogerd HP, Tsai K, Heaton NS, Cullen BR.

Cell Host Microbe. 2017 Sep 13;22(3):377-386.e5. doi: 10.1016/j.chom.2017.08.004.

6.

Induced Packaging of Cellular MicroRNAs into HIV-1 Virions Can Inhibit Infectivity.

Bogerd HP, Kennedy EM, Whisnant AW, Cullen BR.

MBio. 2017 Jan 17;8(1). pii: e02125-16. doi: 10.1128/mBio.02125-16.

7.

Partial reconstitution of the RNAi response in human cells using Drosophila gene products.

Kennedy EM, Kornepati AV, Bogerd HP, Cullen BR.

RNA. 2017 Feb;23(2):153-160. doi: 10.1261/rna.059345.116. Epub 2016 Nov 11.

8.

Posttranscriptional m(6)A Editing of HIV-1 mRNAs Enhances Viral Gene Expression.

Kennedy EM, Bogerd HP, Kornepati AV, Kang D, Ghoshal D, Marshall JB, Poling BC, Tsai K, Gokhale NS, Horner SM, Cullen BR.

Cell Host Microbe. 2016 May 11;19(5):675-85. doi: 10.1016/j.chom.2016.04.002. Epub 2016 Apr 21. Erratum in: Cell Host Microbe. 2017 Dec 13;22(6):830.

9.

Specific induction of endogenous viral restriction factors using CRISPR/Cas-derived transcriptional activators.

Bogerd HP, Kornepati AV, Marshall JB, Kennedy EM, Cullen BR.

Proc Natl Acad Sci U S A. 2015 Dec 29;112(52):E7249-56. doi: 10.1073/pnas.1516305112. Epub 2015 Dec 14.

10.

Production of functional small interfering RNAs by an amino-terminal deletion mutant of human Dicer.

Kennedy EM, Whisnant AW, Kornepati AV, Marshall JB, Bogerd HP, Cullen BR.

Proc Natl Acad Sci U S A. 2015 Dec 15;112(50):E6945-54. doi: 10.1073/pnas.1513421112. Epub 2015 Nov 30. Erratum in: Proc Natl Acad Sci U S A. 2016 Oct 18;113(42):E6547.

11.

Optimization of a multiplex CRISPR/Cas system for use as an antiviral therapeutic.

Kennedy EM, Kornepati AVR, Mefferd AL, Marshall JB, Tsai K, Bogerd HP, Cullen BR.

Methods. 2015 Dec;91:82-86. doi: 10.1016/j.ymeth.2015.08.012. Epub 2015 Aug 17.

12.

Expression of CRISPR/Cas single guide RNAs using small tRNA promoters.

Mefferd AL, Kornepati AV, Bogerd HP, Kennedy EM, Cullen BR.

RNA. 2015 Sep;21(9):1683-9. doi: 10.1261/rna.051631.115. Epub 2015 Jul 17.

13.

Suppression of hepatitis B virus DNA accumulation in chronically infected cells using a bacterial CRISPR/Cas RNA-guided DNA endonuclease.

Kennedy EM, Bassit LC, Mueller H, Kornepati AVR, Bogerd HP, Nie T, Chatterjee P, Javanbakht H, Schinazi RF, Cullen BR.

Virology. 2015 Feb;476:196-205. doi: 10.1016/j.virol.2014.12.001. Epub 2014 Dec 29.

14.

Inactivation of the human papillomavirus E6 or E7 gene in cervical carcinoma cells by using a bacterial CRISPR/Cas RNA-guided endonuclease.

Kennedy EM, Kornepati AV, Goldstein M, Bogerd HP, Poling BC, Whisnant AW, Kastan MB, Cullen BR.

J Virol. 2014 Oct;88(20):11965-72. doi: 10.1128/JVI.01879-14. Epub 2014 Aug 6.

15.

Replication of many human viruses is refractory to inhibition by endogenous cellular microRNAs.

Bogerd HP, Skalsky RL, Kennedy EM, Furuse Y, Whisnant AW, Flores O, Schultz KL, Putnam N, Barrows NJ, Sherry B, Scholle F, Garcia-Blanco MA, Griffin DE, Cullen BR.

J Virol. 2014 Jul;88(14):8065-76. doi: 10.1128/JVI.00985-14. Epub 2014 May 7.

16.

Derivation and characterization of Dicer- and microRNA-deficient human cells.

Bogerd HP, Whisnant AW, Kennedy EM, Flores O, Cullen BR.

RNA. 2014 Jun;20(6):923-37. doi: 10.1261/rna.044545.114. Epub 2014 Apr 22.

17.

In-depth analysis of the interaction of HIV-1 with cellular microRNA biogenesis and effector mechanisms.

Whisnant AW, Bogerd HP, Flores O, Ho P, Powers JG, Sharova N, Stevenson M, Chen CH, Cullen BR.

MBio. 2013 Apr 16;4(2):e000193. doi: 10.1128/mBio.00193-13.

18.

Human APOBEC3 proteins can inhibit xenotropic murine leukemia virus-related virus infectivity.

Bogerd HP, Zhang F, Bieniasz PD, Cullen BR.

Virology. 2011 Feb 5;410(1):234-9. doi: 10.1016/j.virol.2010.11.011. Epub 2010 Dec 4.

19.

A mammalian herpesvirus uses noncanonical expression and processing mechanisms to generate viral MicroRNAs.

Bogerd HP, Karnowski HW, Cai X, Shin J, Pohlers M, Cullen BR.

Mol Cell. 2010 Jan 15;37(1):135-42. doi: 10.1016/j.molcel.2009.12.016.

20.

Equine infectious anemia virus resists the antiretroviral activity of equine APOBEC3 proteins through a packaging-independent mechanism.

Bogerd HP, Tallmadge RL, Oaks JL, Carpenter S, Cullen BR.

J Virol. 2008 Dec;82(23):11889-901. doi: 10.1128/JVI.01537-08. Epub 2008 Sep 25.

21.

Single-stranded RNA facilitates nucleocapsid: APOBEC3G complex formation.

Bogerd HP, Cullen BR.

RNA. 2008 Jun;14(6):1228-36. doi: 10.1261/rna.964708. Epub 2008 May 2.

22.

The intrinsic antiretroviral factor APOBEC3B contains two enzymatically active cytidine deaminase domains.

Bogerd HP, Wiegand HL, Doehle BP, Cullen BR.

Virology. 2007 Aug 1;364(2):486-93. Epub 2007 Apr 16.

23.

Selective inhibition of Alu retrotransposition by APOBEC3G.

Hulme AE, Bogerd HP, Cullen BR, Moran JV.

Gene. 2007 Apr 1;390(1-2):199-205. Epub 2006 Sep 27.

24.

The betaretrovirus Mason-Pfizer monkey virus selectively excludes simian APOBEC3G from virion particles.

Doehle BP, Bogerd HP, Wiegand HL, Jouvenet N, Bieniasz PD, Hunter E, Cullen BR.

J Virol. 2006 Dec;80(24):12102-8. Epub 2006 Oct 11.

25.

Cellular inhibitors of long interspersed element 1 and Alu retrotransposition.

Bogerd HP, Wiegand HL, Hulme AE, Garcia-Perez JL, O'Shea KS, Moran JV, Cullen BR.

Proc Natl Acad Sci U S A. 2006 Jun 6;103(23):8780-5. Epub 2006 May 25.

26.

APOBEC3A and APOBEC3B are potent inhibitors of LTR-retrotransposon function in human cells.

Bogerd HP, Wiegand HL, Doehle BP, Lueders KK, Cullen BR.

Nucleic Acids Res. 2006 Jan 10;34(1):89-95. Print 2006.

27.

Differential sensitivity of murine leukemia virus to APOBEC3-mediated inhibition is governed by virion exclusion.

Doehle BP, Schäfer A, Wiegand HL, Bogerd HP, Cullen BR.

J Virol. 2005 Jul;79(13):8201-7.

28.
29.

A second human antiretroviral factor, APOBEC3F, is suppressed by the HIV-1 and HIV-2 Vif proteins.

Wiegand HL, Doehle BP, Bogerd HP, Cullen BR.

EMBO J. 2004 Jun 16;23(12):2451-8. Epub 2004 May 20.

30.

A single amino acid difference in the host APOBEC3G protein controls the primate species specificity of HIV type 1 virion infectivity factor.

Bogerd HP, Doehle BP, Wiegand HL, Cullen BR.

Proc Natl Acad Sci U S A. 2004 Mar 16;101(11):3770-4. Epub 2004 Mar 3.

31.

Both ran and importins have the ability to function as nuclear mRNA export factors.

Yi R, Bogerd HP, Wiegand HL, Cullen BR.

RNA. 2002 Feb;8(2):180-7.

33.

Formation of Tap/NXT1 heterodimers activates Tap-dependent nuclear mRNA export by enhancing recruitment to nuclear pore complexes.

Wiegand HL, Coburn GA, Zeng Y, Kang Y, Bogerd HP, Cullen BR.

Mol Cell Biol. 2002 Jan;22(1):245-56.

34.

Two closely related human nuclear export factors utilize entirely distinct export pathways.

Yang J, Bogerd HP, Wang PJ, Page DC, Cullen BR.

Mol Cell. 2001 Aug;8(2):397-406.

35.
37.

Functional differences between human and bovine immunodeficiency virus Tat transcription factors.

Bogerd HP, Wiegand HL, Bieniasz PD, Cullen BR.

J Virol. 2000 May;74(10):4666-71.

38.

An ancient family of human endogenous retroviruses encodes a functional homolog of the HIV-1 Rev protein.

Yang J, Bogerd HP, Peng S, Wiegand H, Truant R, Cullen BR.

Proc Natl Acad Sci U S A. 1999 Nov 9;96(23):13404-8.

39.
40.
41.

Highly divergent lentiviral Tat proteins activate viral gene expression by a common mechanism.

Bieniasz PD, Grdina TA, Bogerd HP, Cullen BR.

Mol Cell Biol. 1999 Jul;19(7):4592-9.

43.

Definition of a consensus transportin-specific nucleocytoplasmic transport signal.

Bogerd HP, Benson RE, Truant R, Herold A, Phingbodhipakkiya M, Cullen BR.

J Biol Chem. 1999 Apr 2;274(14):9771-7.

44.
46.
47.

A nuclear role for the Fragile X mental retardation protein.

Fridell RA, Benson RE, Hua J, Bogerd HP, Cullen BR.

EMBO J. 1996 Oct 1;15(19):5408-14.

49.

Nuclear export of late HIV-1 mRNAs occurs via a cellular protein export pathway.

Fridell RA, Bogerd HP, Cullen BR.

Proc Natl Acad Sci U S A. 1996 Apr 30;93(9):4421-4.

50.

Identification of a novel cellular cofactor for the Rev/Rex class of retroviral regulatory proteins.

Bogerd HP, Fridell RA, Madore S, Cullen BR.

Cell. 1995 Aug 11;82(3):485-94.

Supplemental Content

Loading ...
Support Center